The implication of a reduced-dose hepatitis B vaccination schedule in low risk newborns

By Lee S.S.   Young B.W.Y.   Wong K.H.   Lim W.L.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3752-3754

Elsevier

Access to resources Recommend Favorite

Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children

By Egemen A.   Aksit S.   Kurugol Z.   Erensoy S.   Bilgic A.   Akilli M.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1511-1515

Elsevier

Access to resources Recommend Favorite

Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan

By Lin D.-B.   Wang H.-M.   Lee Y.-L.   Ling U.-P.   Changlai S.-P.   Chen C.-J.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1683-1687

Elsevier

Access to resources Recommend Favorite

Central demyelinating disorders and hepatitis B vaccination: a risk-benefit approach for pre-adolescent vaccination in France

By Levy-Bruhl D.   Desenclos J.-C.   Rebiere I.   Drucker J.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2065-2071

Elsevier

Access to resources Recommend Favorite

Hepatitis B vaccination: how to reach risk groups

By Francois G.   Hallauer J.   Van Damme P.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 1-4

Elsevier

Access to resources Recommend Favorite